Association Between Fat Mass to Lean Body Mass Ratio and All-Cause Mortality Among Middle-Aged and Elderly Cancer Patients Without Obesity: A Multi-Center Observational Study in China.
all-cause mortality
elderly cancer patients
fat mass
fat mass to lean body mass ratio
percentage of body fat
Journal
Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
04
2022
accepted:
20
05
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
6
7
2022
Statut:
epublish
Résumé
We aimed to investigate the association between fat mass to lean body mass ratio (RFL), percentage of body fat (PBF), and fat mass (FM) with mortality among middle-aged and elderly cancer patients without obesity. This prospective hospital-based cohort study comprised 3,201 patients with stage I to IV cancer aged 40 years or above (mean age: 58 years for female patients and 61 years for male patients; mean length of follow-up was 1.67 years; the maximal follow-up length was 6.42 years). FM and PBF were measured by bioelectrical impedance analysis (BIA). Cox proportional hazard models were used, and adjusted hazard ratios (HRs) were estimated. We revealed a significant association between RFL and all-cause mortality among men aged ≥60 years after adjusting for confounders. Compared with those in the lowest tertile of RFL, elderly men in the medium and highest tertile had a 35 and 34% lower hazard of death from any cause, respectively. After additionally adjusted for C-reaction protein (CRP), HRs of medium and high tertile of RFL became short of statistical significance [medium tertile: adjusted HRs (95% CI) = 0.74 (0.46, 1.20); highest tertile: adjusted HRs (95% CI) = 0.84 (0.53, 1.33)]. Among elderly women, RFL was significantly related to all-cause mortality only when the additional adjustment for CRP [medium tertile: adjusted HRs (95% CI) = 2.08 (1.08, 4.01); highest tertile: adjusted HRs (95% CI) = 0.90 (0.45, 1.81)]. No significant association between RFL and all-cause mortality was observed among female participants or male participants aged less than 60 years. Our findings showed a significant non-linear association between RFL and all-cause mortality, which was observed only in elderly men, and might be attenuated by their inflammation state.
Identifiants
pubmed: 35789967
doi: 10.3389/fnut.2022.914020
pmc: PMC9249599
doi:
Types de publication
Journal Article
Langues
eng
Pagination
914020Investigateurs
Zengqing Guo
(Z)
Zhenming Fu
(Z)
Chang Wang
(C)
Min Weng
(M)
Jingjing Cao
(J)
Fuxiang Zhou
(F)
Yuan Lin
(Y)
Suyi Li
(S)
Yi Ba
(Y)
Kaitao Yuan
(K)
Ming Liu
(M)
Wen Hu
(W)
Lan Zhou
(L)
Hu Ma
(H)
Qinghua Yao
(Q)
Minghua Cong
(M)
Tao Li
(T)
Zihua Chen
(Z)
Gongyan Chen
(G)
Qingchuan Zhao
(Q)
Changyan Feng
(C)
Ying He
(Y)
Jing Wu
(J)
Jiajun Yang
(J)
Xinxia Song
(X)
Yaying Yu
(Y)
Wenjun Ma
(W)
Suxia Luo
(S)
Jin Zheng
(J)
Junqiang Chen
(J)
Qi Luo
(Q)
Wei Wang
(W)
Qiuge Qiao
(Q)
Yongmei Shi
(Y)
Yumei Qi
(Y)
Yongdong Feng
(Y)
Haiping Jiang
(H)
Wenxian Guan
(W)
Jiaxin Chen
(J)
He Huang
(H)
Zheng Yu
(Z)
Yu Fang
(Y)
Informations de copyright
Copyright © 2022 Xue, Du, Xie, Zhai, Song, Luo, Qiu, Wang, Cui, Song, Xu, Li, Shi, Li and The Investigation on Nutrition Status and Its Clinical Outcome of Common Cancers (INSCOC) Group.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Gut. 2013 Jun;62(6):933-47
pubmed: 23481261
Hepatol Commun. 2022 May 3;:
pubmed: 35503803
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):317-326
pubmed: 27897432
J Clin Oncol. 2016 Dec 10;34(35):4270-4276
pubmed: 27903155
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
Am J Clin Nutr. 2002 Jun;75(6):1107-13
pubmed: 12036820
Eur Spine J. 2019 May;28(5):914-921
pubmed: 30729293
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
BMJ. 2018 Jul 3;362:k2575
pubmed: 29970408
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Front Immunol. 2019 Apr 30;10:943
pubmed: 31114584
Diabetes Metab Syndr Obes. 2019 Aug 14;12:1399-1407
pubmed: 31616170
Nutrition. 2022 Feb;94:111508
pubmed: 34813982
Methods Mol Biol. 2008;423:449-60
pubmed: 18370221
J Biol Chem. 2004 Nov 19;279(47):48487-90
pubmed: 15337754
J Womens Health (Larchmt). 2007 Mar;16(2):168-76
pubmed: 17388733
Ann Palliat Med. 2019 Jan;8(1):3-12
pubmed: 30685982
Crit Rev Oncol Hematol. 2011 Feb;77(2):142-7
pubmed: 20185330
Obes Rev. 2016 Feb;17(2):95-107
pubmed: 26696565
Obes Facts. 2017;10(3):207-215
pubmed: 28564650
Diabetes Res Clin Pract. 2011 Aug;93(2):285-291
pubmed: 21752483
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Clin Oncol. 2016 Dec 10;34(35):4203-4216
pubmed: 27903149
Nutrition. 2020 Apr;72:110695
pubmed: 32007806
Annu Rev Pathol. 2016 May 23;11:421-49
pubmed: 27193454
Front Nutr. 2020 Nov 26;7:600612
pubmed: 33324671
N Engl J Med. 2000 Dec 21;343(25):1826-32
pubmed: 11117973
Clin Nutr. 2021 Jun;40(6):4201-4208
pubmed: 33583658
N Engl J Med. 2006 Aug 24;355(8):763-78
pubmed: 16926275
Nutrients. 2020 Jan 17;12(1):
pubmed: 31963454
Curr Opin Pharmacol. 2016 Aug;29:77-89
pubmed: 27429211
Int J Epidemiol. 2012 Apr;41(2):472-81
pubmed: 22296991
Adv Exp Med Biol. 2017;960:571-606
pubmed: 28585217
JAMA Oncol. 2021 Jun 04;:
pubmed: 34086040
JAMA Oncol. 2018 Jun 1;4(6):798-804
pubmed: 29621380
Clin Nutr. 2003 Jun;22(3):321-36
pubmed: 12765673
Muscle Nerve. 2016 Oct;54(4):743-9
pubmed: 26969901
Radiat Oncol J. 2012 Sep;30(3):132-9
pubmed: 23170292
Exp Gerontol. 2019 Apr;118:65-71
pubmed: 30641106
Circ Cardiovasc Qual Outcomes. 2021 Jun;14(6):e007292
pubmed: 34107739